Journal of Clinical Endocrinology & Metabolism, Vol 78, 205-210, Copyright © 1994 by Endocrine Society

ARTICLES

Local production and action of follistatin in human placenta

F Petraglia, A Gallinelli, A Grande, P Florio, S Ferrari, AR Genazzani, N Ling and LV DePaolo
Department of Obstetric and Gynecology, University of Modena, School of Medicine, Italy.

The aim of the present study was to investigate the possible production, localization, and action of follistatin in human placenta, fetal membranes (amnion, chorion), and maternal decidua. Four different experimental approaches were used: 1) Southern blot analysis following reverse polymerase chain reaction to identify follistatin messenger RNA (mRNA) in tissue homogenates; 2) immunohistochemistry to localize immunoreactive (ir-) follistatin in the various intrauterine tissues; 3) measurement by RIA of ir-follistatin levels in culture medium of placental cells; and 4) possible action of follistatin on human CG (hCG) and progesterone release from cultured placental cells. Placental and decidual cells collected during first trimester or at term gestation express follistatin mRNA; fetal membranes (amnion, chorion) at term also express follistatin mRNA. Immunoreactive follistatin is localized in syncytial cells of placental villi at term as well as in large decidual cells, in amnion epithelium, and in chorionic cells. The placental secretion of follistatin has been confirmed by the evidence of measurable levels of ir-follistatin in the medium of cultured placental cells at term; the release is time dependent and is not modified by the addition of forskolin or progesterone. The addition of increasing doses of recombinant human follistatin does not significantly influence the release of hCG or progesterone from cultured placental cells, whereas the activin A-induced hCG and progesterone release are completely reversed. The present data showed that 1) human placenta, fetal membranes, and decidua express follistatin mRNA; 2) ir-follistatin is localized and released from placental cells at term; and 3) follistatin has a functional role in the local control system regulating placental hormone production.

This article has been cited by other articles:

				N. Antony, J. J. Bass, C. D. McMahon, and M. D. Mitchell Myostatin regulates glucose uptake in BeWo cells Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1296 - E1302. [Abstract] [Full Text] [PDF]

				C. Ferretti, L. Bruni, V. Dangles-Marie, A.P. Pecking, and D. Bellet Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts Hum. Reprod. Update, March 1, 2007; 13(2): 121 - 141. [Abstract] [Full Text] [PDF]

				R. Sood, J. L. Zehnder, M. L. Druzin, and P. O. Brown Gene expression patterns in human placenta PNAS, April 4, 2006; 103(14): 5478 - 5483. [Abstract] [Full Text] [PDF]

				H.-Q. Wang, K. Takebayashi, K. Tsuchida, M. Nishimura, and Y. Noda Follistatin-Related Gene (FLRG) Expression in Human Endometrium: Sex Steroid Hormones Regulate the Expression of FLRG in Cultured Human Endometrial Stromal Cells J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4432 - 4439. [Abstract] [Full Text] [PDF]

				H. J. Roberts, S. Hu, Q. Qiu, P. C.K. Leung, I. Caniggia, A. Gruslin, B. Tsang, and C. Peng Identification of Novel Isoforms of Activin Receptor-Like Kinase 7 (ALK7) Generated by Alternative Splicing and Expression of ALK7 and Its Ligand, Nodal, in Human Placenta Biol Reprod, May 1, 2003; 68(5): 1719 - 1726. [Abstract] [Full Text] [PDF]

				S. Luo, H. Yu, D. Wu, and C. Peng Transforming growth factor-{beta}1 inhibits steroidogenesis in human trophoblast cells Mol. Hum. Reprod., April 1, 2002; 8(4): 318 - 325. [Abstract] [Full Text] [PDF]

				R. L. Jones, L. A. Salamonsen, Y. C. Zhao, J.-F. Ethier, A. E. Drummond, and J. K. Findlay Expression of activin receptors, follistatin and betaglycan by human endometrial stromal cells; consistent with a role for activins during decidualization Mol. Hum. Reprod., April 1, 2002; 8(4): 363 - 374. [Abstract] [Full Text] [PDF]

				J. A. Keelan, R. L. Zhou, L. W. Evans, N. P. Groome, and M. D. Mitchell Regulation of Activin A, Inhibin A, and Follistatin Production in Human Amnion and Choriodecidual Explants by Inflammatory Mediators Reproductive Sciences, September 1, 2000; 7(5): 291 - 296. [Abstract] [PDF]

				X. Ni, S. Luo, T. Minegishi, and C. Peng Activin A in JEG-3 Cells: Potential Role as an Autocrine Regulator of Steroidogenesis in Humans Biol Reprod, May 1, 2000; 62(5): 1224 - 1230. [Abstract] [Full Text]

				J. C. CROSS Formation of the Placenta and Extraembryonic Membranes Ann. N.Y. Acad. Sci., October 23, 1998; 857(1): 23 - 32. [Abstract] [Full Text] [PDF]

				T. Kohsaka,, G. Min,, G. Lukas,, S. Trupin,, E. T. Campbell,, and O. D. Sherwood Identification of Specific Relaxin-Binding Cells in the Human Female Biol Reprod, October 1, 1998; 59(4): 991 - 999. [Abstract] [Full Text]

				D. S. McConnell, Q. Wang, P. M. Sluss, N. Bolf, R. H. Khoury, A. L. Schneyer, A. R. Midgley Jr., N. E. Reame, W. F. Crowley Jr., and V. Padmanabhan A Two-Site Chemiluminescent Assay for Activin-Free Follistatin Reveals That Most Follistatin Circulating in Men and Normal Cycling Women Is in an Activin-Bound State J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 851 - 858. [Abstract] [Full Text]

				I. Caniggia, S. J. Lye, and J. C. Cross Activin Is a Local Regulator of Human Cytotrophoblast Cell Differentiation Endocrinology, September 1, 1997; 138(9): 3976 - 3986. [Abstract] [Full Text] [PDF]